FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031409969> ?p ?o ?g. }

• W2031409969 abstract "Breast cancer consists of multiple different molecular subtypes and different biological processes, and consequently different molecular markers are associated with prognosis and chemotherapy sensitivity in the distinct disease subsets [1]. A large number of biological processes including cell cycle regulation, DNA replication, mitotic spindle checkpoint, and p53 function are strongly prognostic in ER+ cancers but not among ER- cancers [2,3]. Interestingly, the number of biological pathways, and therefore genes, that are associated with prognosis or treatment sensitivity are substantially larger and more consistent in ER+ cancers than among ER- tumors [1,4]. This implies that it is easier to discover prognostic and predictive markers for ER+ than for ER- cancers. In ER- cancers, the single most consistent, but still modestly accurate, good prognostic predictor is the presence of immune cell infiltration [5]. Immune cell signatures are also associated with more favorable prognosis in highly proliferative ER+ cancers but not in ER+ cancers with low proliferation [6].It is also increasingly clear that the same molecular marker can be associated with several different outcome endpoints in various and often opposing manners. For example, high Ki67 expression is predictive of worse prognosis in the absence of any systemic therapy in ER+ cancers, but at the same time it is also predictive of higher sensitivity to chemotherapy. Similar opposing bidirectional associations with treatment response and prognosis exist for many other markers including histologic grade, Tau protein expression and almost all prognostic gene signatures [7].It is important to be aware of these complex multi-directional interactions between molecular markers and various clinical endpoints that may also vary from breast cancer subtype to subtype. Ignoring these potential marker-disease subset-outcome interactions can lead to contradictory and confusing results across studies (due to differences in patient composition and heterogeneity of therapy between studies) and may also lead to the discovery of biomarkers that are clinically less useful (because of unrecognized subtype-restricted performance) [8,9]." @default.
• W2031409969 created "2016-06-24" @default.
• W2031409969 creator A5021113979 @default.
• W2031409969 date "2011-11-16" @default.
• W2031409969 modified "2023-10-06" @default.
• W2031409969 title "Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer" @default.
• W2031409969 cites W1969908200 @default.
• W2031409969 cites W2008702365 @default.
• W2031409969 cites W2028236537 @default.
• W2031409969 cites W2110426068 @default.
• W2031409969 cites W2118949116 @default.
• W2031409969 cites W2120742047 @default.
• W2031409969 cites W2123089413 @default.
• W2031409969 cites W2169360530 @default.
• W2031409969 doi "https://doi.org/10.1186/bcr3000" @default.
• W2031409969 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3247034" @default.
• W2031409969 hasPublicationYear "2011" @default.
• W2031409969 type Work @default.
• W2031409969 sameAs 2031409969 @default.
• W2031409969 citedByCount "0" @default.
• W2031409969 crossrefType "journal-article" @default.
• W2031409969 hasAuthorship W2031409969A5021113979 @default.
• W2031409969 hasBestOaLocation W20314099691 @default.
• W2031409969 hasConcept C104317684 @default.
• W2031409969 hasConcept C121608353 @default.
• W2031409969 hasConcept C126322002 @default.
• W2031409969 hasConcept C143998085 @default.
• W2031409969 hasConcept C2776694085 @default.
• W2031409969 hasConcept C2780140570 @default.
• W2031409969 hasConcept C502942594 @default.
• W2031409969 hasConcept C530470458 @default.
• W2031409969 hasConcept C54355233 @default.
• W2031409969 hasConcept C60644358 @default.
• W2031409969 hasConcept C71924100 @default.
• W2031409969 hasConcept C86803240 @default.
• W2031409969 hasConceptScore W2031409969C104317684 @default.
• W2031409969 hasConceptScore W2031409969C121608353 @default.
• W2031409969 hasConceptScore W2031409969C126322002 @default.
• W2031409969 hasConceptScore W2031409969C143998085 @default.
• W2031409969 hasConceptScore W2031409969C2776694085 @default.
• W2031409969 hasConceptScore W2031409969C2780140570 @default.
• W2031409969 hasConceptScore W2031409969C502942594 @default.
• W2031409969 hasConceptScore W2031409969C530470458 @default.
• W2031409969 hasConceptScore W2031409969C54355233 @default.
• W2031409969 hasConceptScore W2031409969C60644358 @default.
• W2031409969 hasConceptScore W2031409969C71924100 @default.
• W2031409969 hasConceptScore W2031409969C86803240 @default.
• W2031409969 hasIssue "S2" @default.
• W2031409969 hasLocation W20314099691 @default.
• W2031409969 hasLocation W20314099692 @default.
• W2031409969 hasLocation W20314099693 @default.
• W2031409969 hasOpenAccess W2031409969 @default.
• W2031409969 hasPrimaryLocation W20314099691 @default.
• W2031409969 hasRelatedWork W2013809648 @default.
• W2031409969 hasRelatedWork W2076957192 @default.
• W2031409969 hasRelatedWork W2272325144 @default.
• W2031409969 hasRelatedWork W2367105124 @default.
• W2031409969 hasRelatedWork W2379009234 @default.
• W2031409969 hasRelatedWork W2379151083 @default.
• W2031409969 hasRelatedWork W2388730008 @default.
• W2031409969 hasRelatedWork W2791179561 @default.
• W2031409969 hasRelatedWork W3193380953 @default.
• W2031409969 hasRelatedWork W3201218675 @default.
• W2031409969 hasVolume "13" @default.
• W2031409969 isParatext "false" @default.
• W2031409969 isRetracted "false" @default.
• W2031409969 magId "2031409969" @default.
• W2031409969 workType "article" @default.